A detailed history of Israel Englander (Millennium Management LLC) transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 103,321 shares of RPTX stock, worth $139,483. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,321
Previous 249,475 58.58%
Holding current value
$139,483
Previous $823,000 56.87%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.75 - $3.99 $401,923 - $583,154
-146,154 Reduced 58.58%
103,321 $355,000
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $243,442 - $378,867
80,610 Added 47.74%
249,475 $823,000
Q1 2024

May 15, 2024

SELL
$4.53 - $8.41 $59,940 - $111,281
-13,232 Reduced 7.27%
168,865 $795,000
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $170,495 - $624,268
52,949 Added 41.0%
182,097 $1.33 Million
Q2 2023

Aug 14, 2023

SELL
$8.63 - $12.53 $2.6 Million - $3.77 Million
-300,722 Reduced 69.96%
129,148 $1.37 Million
Q1 2023

May 15, 2023

SELL
$9.32 - $15.06 $1.63 Million - $2.64 Million
-175,417 Reduced 28.98%
429,870 $4.23 Million
Q4 2022

Feb 14, 2023

BUY
$12.5 - $18.13 $4.47 Million - $6.49 Million
357,966 Added 144.74%
605,287 $8.9 Million
Q3 2022

Nov 14, 2022

BUY
$11.57 - $15.59 $1.89 Million - $2.54 Million
163,126 Added 193.75%
247,321 $3 Million
Q2 2022

Aug 15, 2022

SELL
$8.45 - $14.84 $1.15 Million - $2.02 Million
-135,959 Reduced 61.76%
84,195 $1.18 Million
Q1 2022

May 16, 2022

SELL
$11.38 - $21.88 $1.26 Million - $2.42 Million
-110,672 Reduced 33.45%
220,154 $3.14 Million
Q4 2021

Feb 14, 2022

BUY
$19.66 - $28.11 $3.13 Million - $4.48 Million
159,365 Added 92.95%
330,826 $6.98 Million
Q3 2021

Nov 15, 2021

BUY
$25.71 - $35.24 $3.83 Million - $5.25 Million
148,876 Added 659.18%
171,461 $4.5 Million
Q2 2021

Aug 16, 2021

BUY
$30.1 - $34.85 $679,808 - $787,087
22,585 New
22,585 $704,000
Q1 2021

May 17, 2021

SELL
$25.89 - $44.46 $2.46 Million - $4.22 Million
-95,018 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$23.42 - $39.5 $2.22 Million - $3.74 Million
-94,627 Reduced 49.9%
95,018 $3.26 Million
Q3 2020

Nov 16, 2020

SELL
$21.55 - $33.92 $724,058 - $1.14 Million
-33,599 Reduced 15.05%
189,645 $5.84 Million
Q2 2020

Aug 14, 2020

BUY
$30.8 - $32.99 $6.88 Million - $7.36 Million
223,244 New
223,244 $6.93 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.